Your Medication Management Partner
Unlocking better outcomes through precision health technology
![hsa/fsa eligible logo](https://genomind.com/wp-content/uploads/2022/01/hsafsa-LtGray.png)
![hippa compliant logo](https://genomind.com/wp-content/uploads/2022/01/hipaa-LtGray-1030x562.png)
![secure ssl encryption logo](https://genomind.com/wp-content/uploads/2022/01/ssl-img-BW-v2.png)
![cap accredited logo](https://genomind.com/wp-content/uploads/2022/01/CAP-BW-cropped.png)
![clinical laboratory improvement amendments logo](https://genomind.com/wp-content/uploads/2022/01/logos-revised_CLIA-BW-v2.png)
Evolving how we
prescribe medicine
Our understanding of genetics is changing how we prescribe. As the science of medicine evolves, we feel a responsibility to deliver solutions that keep pace with that change.
Our innovative, precision health technology can unlock the ability to deliver personalized treatment. Together we can improve quality, reduce costs, and increase overall satisfaction of care.
![thumbnail of flagship Genomind provider story video with dna connectors and text: Now providers can see hour your other medications and your genetics can impact treatment choices](https://genomind.com/wp-content/uploads/2022/02/CleanShot-2022-02-23-at-18.39.05@2x.png)
Optimizing treatment can take us from harm to healing
Every year people are injured or abandon medications altogether due to side effects or lack of efficacy.
3.2MM
>50%
$528B
52%
Deliver targeted and personalized care
Genomind brings critical prescribing data into one integrated platform, so you can easily manage medications for individual patients or large populations with precision.
![](https://genomind.com/wp-content/uploads/2022/01/Computer_Monitor.png)
Pharmacogenetic (PGx) Testing
Assess your patient’s genetics to personalize dosing and medication choices.
Precision Medicine Software
Identify gene and drug interaction risks while dynamically adjusting to safer alternatives.
Precision Medicine Consults
Access PharmD and PhD experts for training staff, consultations, and more.
Population Health Assessment
Stratify patient populations based on risk for drug-drug and potential gene-drug interactions.
![isalus logo](https://genomind.com/wp-content/uploads/2022/01/isalus-BW-1030x284.png)
![medent logo](https://genomind.com/wp-content/uploads/2022/01/medent_BW.png)
![practice fusion logo](https://genomind.com/wp-content/uploads/2022/01/practicefusion_BW-1030x126.png)
![dr chrono logo](https://genomind.com/wp-content/uploads/2022/01/drchrono_BW-1030x290.png)
![nextgen healthcare logo](https://genomind.com/wp-content/uploads/2022/01/nextgen-logo-color_BW-1030x418.png)
![athena health logo](https://genomind.com/wp-content/uploads/2022/01/athena_BW.png)
![epic logo](https://genomind.com/wp-content/uploads/2022/01/Epic_BW.png)
Coming Soon
![cerner logo](https://genomind.com/wp-content/uploads/2022/01/cerner_BW.png)
Improving the patient care experience
Associated with reducing hospitalizations and individual healthcare costs
What's new in precision medicine
Learn in person, virtually, or at your own pace through our education platform, Genomind 360.
![Register for the webinar!](https://genomind.com/wp-content/uploads/2023/11/23_Grand-Rounds_11-30_Perlis-Scary-Good-or-Just-Scary-AI-in-Psych_v1-1030x583.png)
Scary Good or Just Scary? Al in Psychiatry
Join Genomind and guest speaker, Roy H. Perlis, MD, MSc, on a journey through cutting-edge applications and the potential impact of artificial intelligence on mental
![Grand Rounds Event Card Cannabis Conundrum](https://genomind.com/wp-content/uploads/2023/09/Cannabis-Conundrum-Email-1030x579.png)
Cannabis Conundrum – Role of Cannabis Use in Persons with Psychotic Disorders
Register for Genomind’s upcoming clinical education webinar on utilizing medical cannabis in clinical pharmacology.
![](https://genomind.com/wp-content/uploads/2023/09/Whats-New-About-Depression-in-Older-Adults-Imager-1030x579.png)
What’s New About Depression in Older Adults?
Register for Genomind’s upcoming clinical education webinar on utilizing medical cannabis in clinical pharmacology.